Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity
about
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency.Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors.Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement.A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling.
P2860
Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@ast
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@en
type
label
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@ast
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@en
prefLabel
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@ast
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@en
P2093
P2860
P1433
P1476
Conversion of a Single Polypha ...... Intracellular Kinase Activity
@en
P2093
Carrie M Gower
Edmund Harrington
Ivan Cornella-Taracido
Jason Murphy
Jason R Thomas
Markus Schirle
Matthew E K Chang
Rishi K Jain
P2860
P304
P356
10.1021/ACSCHEMBIO.5B00847
P407
P577
2016-01-15T00:00:00Z